B-Raf IN 2 structure
|
Common Name | B-Raf IN 2 | ||
|---|---|---|---|---|
| CAS Number | 2649372-20-1 | Molecular Weight | 461.44 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H17F2N5O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of B-Raf IN 2B-Raf IN 2 is a potent and selective BRAF inhibitor extracted from patent WO2021116055A1, compound Ia. B-Raf IN 2 can be used for the research of cancer[1]. |
| Name | B-Raf IN 2 |
|---|
| Description | B-Raf IN 2 is a potent and selective BRAF inhibitor extracted from patent WO2021116055A1, compound Ia. B-Raf IN 2 can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
BRafV600E |
| In Vitro | B-Raf IN 2 shows considerably less paradoxial activation of the MAPK signaling pathway while retaining high potency[1]. |
| References |
[1]. Dolente C, et, al. New methylquinazolinone derivatives. WO2021116055A1. |
| Molecular Formula | C20H17F2N5O4S |
|---|---|
| Molecular Weight | 461.44 |